Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients

Diabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese typ...

Full description

Saved in:
Bibliographic Details
Main Authors: YongWei Jiang, Liang Ma, ChengWu Han, Qian Liu, Xiao Cong, YaPing Xu, TingTing Zhao, Ping Li, YongTong Cao
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/3560920
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564109124567040
author YongWei Jiang
Liang Ma
ChengWu Han
Qian Liu
Xiao Cong
YaPing Xu
TingTing Zhao
Ping Li
YongTong Cao
author_facet YongWei Jiang
Liang Ma
ChengWu Han
Qian Liu
Xiao Cong
YaPing Xu
TingTing Zhao
Ping Li
YongTong Cao
author_sort YongWei Jiang
collection DOAJ
description Diabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese type 2 diabetic patients. We studied 845 diabetic patients who were divided into DN group (n=429) and control group (n=416). ApoE genotype was determined by ApoE genotyping chip and the plasmatic biochemical characterization was performed on all subjects. There were differences (P<0.001) in HbA1c, creatinine, and urinary albumin between the two groups. The ApoE ε2 allelic frequency was 7.69% in DN group versus 3.49% in control group (OR = 2.22, 95% CI = 1.41–3.47, and P<0.05), as expected, ApoE E2/E2 and E2/E3 genotype frequency were higher in DN group (13.75% versus 6.49%, P<0.05). The ApoE ε4 allelic frequency was 7.93% in DN group versus 11.54% in control group (OR = 0.70, 95% CI = 0.50–0.97, and P<0.05), and DN group presented a lower frequency of ApoE E3/E4 and E4/E4 genotype frequency (14.91% versus 19.96%, P<0.05). These results suggest ApoE ε2 allele may be a risk factor; however ApoE ε4 allele may play a protective role of DN in Chinese type 2 diabetic patients.
format Article
id doaj-art-204e15062aa7467da7f22a5d54231ee9
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-204e15062aa7467da7f22a5d54231ee92025-02-03T01:11:44ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/35609203560920Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic PatientsYongWei Jiang0Liang Ma1ChengWu Han2Qian Liu3Xiao Cong4YaPing Xu5TingTing Zhao6Ping Li7YongTong Cao8Clinical Laboratory, China-Japan Friendship Hospital, Beijing, ChinaGraduate School of Peking Union Medical College, Beijing, ChinaClinical Laboratory, China-Japan Friendship Hospital, Beijing, ChinaClinical Laboratory, China-Japan Friendship Hospital, Beijing, ChinaClinical Laboratory, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Pathophysiology, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, ChinaBeijing Key Lab Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, ChinaGraduate School of Peking Union Medical College, Beijing, ChinaClinical Laboratory, China-Japan Friendship Hospital, Beijing, ChinaDiabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese type 2 diabetic patients. We studied 845 diabetic patients who were divided into DN group (n=429) and control group (n=416). ApoE genotype was determined by ApoE genotyping chip and the plasmatic biochemical characterization was performed on all subjects. There were differences (P<0.001) in HbA1c, creatinine, and urinary albumin between the two groups. The ApoE ε2 allelic frequency was 7.69% in DN group versus 3.49% in control group (OR = 2.22, 95% CI = 1.41–3.47, and P<0.05), as expected, ApoE E2/E2 and E2/E3 genotype frequency were higher in DN group (13.75% versus 6.49%, P<0.05). The ApoE ε4 allelic frequency was 7.93% in DN group versus 11.54% in control group (OR = 0.70, 95% CI = 0.50–0.97, and P<0.05), and DN group presented a lower frequency of ApoE E3/E4 and E4/E4 genotype frequency (14.91% versus 19.96%, P<0.05). These results suggest ApoE ε2 allele may be a risk factor; however ApoE ε4 allele may play a protective role of DN in Chinese type 2 diabetic patients.http://dx.doi.org/10.1155/2017/3560920
spellingShingle YongWei Jiang
Liang Ma
ChengWu Han
Qian Liu
Xiao Cong
YaPing Xu
TingTing Zhao
Ping Li
YongTong Cao
Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
Journal of Diabetes Research
title Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
title_full Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
title_fullStr Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
title_full_unstemmed Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
title_short Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
title_sort effects of apolipoprotein e isoforms in diabetic nephropathy of chinese type 2 diabetic patients
url http://dx.doi.org/10.1155/2017/3560920
work_keys_str_mv AT yongweijiang effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT liangma effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT chengwuhan effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT qianliu effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT xiaocong effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT yapingxu effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT tingtingzhao effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT pingli effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients
AT yongtongcao effectsofapolipoproteineisoformsindiabeticnephropathyofchinesetype2diabeticpatients